Cart
sales@molnova.com
Elotuzumab
CAS No. 915296-00-3
Elotuzumab( —— )
Catalog No. M34757 CAS No. 915296-00-3
Elotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 347 | Get Quote |
|
| 5MG | 655 | Get Quote |
|
| 10MG | 924 | Get Quote |
|
| 25MG | 1316 | Get Quote |
|
| 50MG | 1776 | Get Quote |
|
| 100MG | 2367 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameElotuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionElotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.
-
DescriptionElotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number915296-00-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Magen H, et al. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment. Ther Adv Hematol. 2016;7(4):187-195.
molnova catalog
related products
-
Luvadaxistat
Luvadaxistat (TAK-831) is an orally active, potent and highly selective inhibitor of D-amino acid oxidase (DAAO) with an IC50 value of 14 nM for the oxidative deamination of D-serine.Luvadaxistat is used in the study of schizophrenia and cognitive disorders.
-
(2E)-3-(3,5-dimethox...
(2E)-3-(3,5-dimethoxyphenyl)-1-(2-methoxyphenyl)prop-2-en-1-one is a chemical compound.
-
ZP-amide C
The herbs of Zanthoxylum armatum.
